GW Pharma’s cannabis drug OK’d by European Medicines Agency panel


GW Pharmaceuticals announced that the Committee for Medicinal Products for Human Use (CHMP) recommended approval of the British company’s cannabis-based medicine Epidiolex. The CHMP is responsible for preparing the European Medicines Agency (EMA)’s opinions on questions related to the marketing of human medicines. The CHMP opinion was adopted July 25, and the final decision now rests […] GW Pharma’s cannabis drug OK’d by European Medicines Agency panel is a post from: Marijuana Business Daily: Financial, Legal & Cannabusiness news for cannabis entrepreneurs
Source: MjBizDaily.com
GW Pharma’s cannabis drug OK’d by European Medicines Agency panel